Search Results - "Singh, Diljeet K"

Human Papillomavirus Infection and Cervical Cytology in HIV‐Infected and HIV‐Uninfected Rwandan Women by Singh, Diljeet K. , Anastos, Kathryn , Hoover, Donald R. , Burk, Robert D. , Shi, Qiuhu , Ngendahayo, Louis , Mutimura, Eugene , Cajigas, Antonio , Bigirimani, Venerand , Cai, Xiaotao , Rwamwejo, Janvier , Vuolo, Magalis , Cohen, Mardge , Castle, Philip E. 

“…Background. Data on human papillomavirus (HPV) prevalence are essential for developing cost‐effective cervical cancer prevention programs. Methods. In 2005,…”
Get full text

The Regulation and Function of the Forkhead Transcription Factor, Forkhead Box O1, Is Dependent on the Progesterone Receptor in Endometrial Carcinoma by Ward, Erin C, Hoekstra, Anna V, Blok, Leen J, Hanifi-Moghaddam, P, Lurain, John R, Singh, Diljeet K, Buttin, Barbara M, Schink, Julian C, Kim, J. Julie

“…In many type I endometrial cancers, the PTEN gene is inactivated, which ultimately leads to constitutively active Akt and the inhibition of Forkhead box O1…”
Get full text

Robotic surgery in gynecologic oncology: Impact on fellowship training by Hoekstra, Anna V, Morgan, Jacqueline M, Lurain, John R, Buttin, Barbara M, Singh, Diljeet K, Schink, Julian C, Lowe, M. Patrick

“…Abstract Objectives To report the impact of a new robotic surgery program on the surgical training of gynecologic oncology fellows over a 12 month period of…”
Get full text

Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women by Anastos, Kathryn, Hoover, Donald R, Burk, Robert D, Cajigas, Antonio, Shi, Qiuhu, Singh, Diljeet K, Cohen, Mardge H, Mutimura, Eugene, Sturgis, Charles, Banzhaf, William C, Castle, Philip E

“…Although cervical cancer is an AIDS-defining condition, infection with human immunodeficiency virus (HIV) may only modestly increase the risk of cervical…”
Get full text

What is Integrative Oncology and Can It Help My Patients? by Pineda, Mario Javier, MD, PhD, Singh, Diljeet K., MD, DrPH

“…Integrative oncology lends itself to the comprehensive practice of gynecologic oncology with multiple tools and interventions that can impact on QoL and…”
Get full text

An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer by Berry, Emily, Matthews, Kellie S, Singh, Diljeet K, Buttin, Barbara M, Lurain, John R, Alvarez, Ronald D, Schink, Julian

“…Abstract Objectives To assess the feasibility, associated toxicities, and reasons for early cessation of an outpatient intraperitoneal (IP) chemotherapy…”
Get full text

Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery by de Oliveira, Jr, Gildasio S, Ahmad, Shireen, Schink, Julian C, Singh, Diljeet K, Fitzgerald, Paul C, McCarthy, Robert J

“…Regional anesthesia has been shown to blunt the response to surgical stress and decrease the use of volatile anesthetics and the consumption of opioids, which…”
Get full text

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors by Weinberg, Lori E, Lurain, John R, Singh, Diljeet K, Schink, Julian C

“…Abstract Objective The objective of this study is to review all malignant germ-cell tumors (MOGCTs) treated at our institution, focusing on reproductive…”
Get full text

Challenges of pelvic imaging in obese women by Glanc, Phyllis, O'Hayon, Bonnie E, Singh, Diljeet K, Bokhari, Syed A J, Maxwell, Cynthia V

“…Obesity is a major global health concern affecting all ages, socioeconomic groups, and countries. Although men have higher rates of overweight, women have…”
Get full text

Predictors of final histology in patients with endometrial cancer by Frumovitz, Michael, Singh, Diljeet K., Meyer, Larissa, Smith, Daniel H., Wertheim, Iris, Resnik, Ephraim, Bodurka, Diane C.

“…To assess the usefulness of preoperative tumor grade and intraoperative assessment of gross depth of myometrial invasion as “predictors” of final grade, final…”
Get full text

Management of Metastatic High-Risk Gestational Trophoblastic Neoplasia: FIGO Stages II―IV: Risk Factor Score > 7 by LURAIN, John R, SINGH, Diljeet K, SCHINK, Julian C

“…To evaluate treatment of metastatic high-risk gestational trophoblastic neoplasia (GTN), including durable complete response rates to chemotherapy, factors…”
Get full text

Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy by LURAIN, John R, SINGH, Diljeet K, SCHINK, Julian C

“…To evaluate the efficacy of etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine (EMA-CO) in the primary treatment of metastatic high-risk…”
Get full text

Role of surgery in the management of high-risk gestational trophoblastic neoplasia by LURAIN, John R, SINGH, Diljeet K, SCHINK, Julian C

“…To evaluate the role of surgery in the management of high-risk gestational trophoblastic neoplasia. Twenty-four (48%) of 50 patients treated with etoposide,…”
Get full text

Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer by Frumovitz, Michael, Slomovitz, Brian M., Singh, Diljeet K., Broaddus, Russell R., Abrams, Jacki, Sun, Charlotte C., Bevers, Michael, Bodurka, Diane C.

“…Many gynecologic oncologists use intraoperative frozen section (IFS) assessment of histologic grade and depth of myometrial invasion (DOI) as predictors of…”
Get full text

FIGO stage IIIC endometrial carcinoma: Prognostic factors and outcomes by Hoekstra, Anna V, Kim, Robert J, Small, William, Rademaker, Alfred W, Helenowski, Irene B, Singh, Diljeet K, Schink, Julian C, Lurain, John R

“…Abstract Objectives Investigate the clinicopathologic characteristics, nodal distribution, and postoperative treatment of patients with FIGO stage IIIC…”
Get full text

Sweet or low: Does hyperglycosylated hCG define a new clinical entity or reveal inadequate care? by Singh, Diljeet K, Lurain, John R

Get full text

The impact of robotics on practice management of endometrial cancer: transitioning from traditional surgery by Hoekstra, Anna V., Jairam-Thodla, Arati, Rademaker, Alfred, Singh, Diljeet K., Buttin, Barbara M., Lurain, John R., Schink, Julian C., Lowe, M. Patrick

“…Background Evaluation of the impact of a new robotic surgery programme on perioperative outcomes for endometrial cancer Methods A prospective database of all…”
Get full text

Weekly topotecan for recurrent platinum resistant ovarian cancer by Abushahin, Fadi, Singh, Diljeet K, Lurain, John R, Grendys, Edward C, Rademaker, Alfred W, Schink, Julian C

“…Abstract Objective. To evaluate toxicity, response and progression-free survival of weekly topotecan chemotherapy in women with primary and secondary…”
Get full text

Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1 by Hoekstra, Anna V, Ward, Erin C, Hardt, Jennifer L, Lurain, John R, Singh, Diljeet K, Buttin, Barbara M, Schink, Julian C, Kim, J. Julie

“…Abstract Objective. Endometrial cancer is the most common type of gynecologic cancer in the United States. In this study, we propose that inhibition of the AKT…”
Get full text

Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy by Escobar, Pedro F, Lurain, John R, Singh, Diljeet K, Bozorgi, Kenny, Fishman, David A

“…The objective of the study was to evaluate the efficacy and toxicity of etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO)…”
Get full text